Institutions / Sector Gamma AS
Sector Gamma AS
CIK 1475373 · Institution · as of Dec 31, 2025
Portfolio value
$438.71M
Positions
36
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 36 →
| Company | Value | % of portfolio |
|---|---|---|
| Bristol Myers Squibb Co | $40.24M | 9.2% |
| Merck & Co., Inc. | $38.28M | 8.7% |
| Medtronic plc | $25.90M | 5.9% |
| Becton Dickinson & Co | $25.69M | 5.9% |
| Gilead Sciences, Inc. | $21.65M | 4.9% |
| Incyte Corp | $21.61M | 4.9% |
| Pfizer Inc | $21.40M | 4.9% |
| Amgen Inc | $19.95M | 4.5% |
| Biogen Inc. | $15.04M | 3.4% |
| Ionis Pharmaceuticals Inc | $14.63M | 3.3% |
| CVS HEALTH Corp | $14.09M | 3.2% |
| Cardinal Health Inc | $12.73M | 2.9% |
| Thermo Fisher Scientific Inc. | $12.57M | 2.9% |
| Bruker Corp | $12.00M | 2.7% |
| Zimmer Biomet Holdings Inc | $11.91M | 2.7% |
| BioMarin Pharmaceutical Inc | $11.80M | 2.7% |
| Elevance Health Inc | $11.41M | 2.6% |
| Centene Corp | $10.62M | 2.4% |
| GE HealthCare Technologies Inc. | $9.38M | 2.1% |
| Edwards Lifesciences Corp | $8.22M | 1.9% |
| Avantor, Inc. | $7.97M | 1.8% |
| Bio-Rad Laboratories, Inc. | $7.20M | 1.6% |
| Labcorp Holdings Inc. | $6.78M | 1.5% |
| Lantheus Holdings, Inc. | $6.24M | 1.4% |
| Tandem Diabetes Care Inc | $5.87M | 1.3% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.